Satoshi Nagao

A Phase 1b Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma: Extended Analysis of Study 116

J. Llovet, R. Finn, A. Baron, 2023, Liver Cancer.